IV Ketamine vs Spravato: Understanding Your Options for Depression and PTSD Treatment

If you are exploring ketamine therapy for depression, PTSD treatment options, or looking for IV ketamine near Cleveland or Strongsville, you may come across two primary approaches: IV ketamine infusions and intranasal ketamine, such as Spravato. Both are valuable tools in modern mental health care, but they differ in how they are delivered, how the body absorbs them, and how treatment is structured over time.

Ketamine works by supporting neuroplasticity, helping the brain form new, healthier connections. This can be especially beneficial for individuals with treatment-resistant depression (TRD) or PTSD, where traditional treatments may not have provided adequate relief. One of the unique aspects of ketamine therapy is how quickly it can work, with many patients noticing improvements within days.

A key concept to understand is bioavailability, which refers to how much of a medication actually reaches the bloodstream and brain. With IV ketamine, bioavailability is nearly 100%, meaning the full dose is delivered directly into circulation. This allows for precise dosing and a highly consistent effect from one treatment to the next.

Intranasal ketamine, including Spravato, has a lower bioavailability, generally around 30 to 50%. This does not mean it is less effective, but rather that absorption can be more variable between patients. Oral ketamine, when used, typically has even lower and less predictable absorption.

Another important difference is how treatment is scheduled. IV ketamine is often given as a short initial series of infusions, followed by maintenance treatments spaced out over time based on the individual’s response. Many patients find that once they respond, treatments can be scheduled weeks to months apart, and some patients may not require maintenance treatments at all.

With Spravato, treatment follows an FDA-approved protocol that begins with more frequent visits, typically twice weekly, then gradually decreases to weekly or every other week. This structured approach can be beneficial for patients who prefer a standardized plan, and it also allows for potential insurance coverage, which is an important consideration for many.

Each option has its advantages. IV ketamine offers precision, flexibility in dosing, and often longer intervals between treatments, which can translate to fewer visits over time. Spravato offers an FDA-approved, protocol-driven approach that may be covered by insurance, providing a more accessible pathway for some patients.

Both treatments are performed in monitored clinical settings and can be effective for treatment-resistant depression and PTSD when delivered thoughtfully and with appropriate follow-up care.

Ultimately, the best choice depends on your individual goals, medical history, and preferences. Some patients prioritize flexibility and fewer treatments over time, while others value insurance coverage and a structured treatment schedule.

For those in the Cleveland and Strongsville area seeking ketamine therapy, understanding these differences is an important first step. At Reset Medical & Wellness Center, we focus on a personalized, trauma-informed approach to care, helping each patient determine which option best fits their needs and long-term goals. At this time, we are utilizing IV ketamine therapy exclusively, while also planning to introduce a Spravato treatment option in the coming months to further expand access and provide additional pathways for care.